Literature DB >> 2989843

Subclinical and clinical bluetongue disease in cattle: clinical, pathological and pathogenic considerations.

G A Anderson, J L Stott, L J Gershwin, B I Osburn.   

Abstract

Calves immunized (sensitized) with alcide-inactivated bluetongue virus (BTV) developed immunoglobulin (Ig) E-specific antibody to BTV. Development of clinically apparent disease occurred after challenge with virulent BTV, and lesions correlated with peak levels of virus-specific IgE, an eosinophilic dermatitis, and high concentrations of histamine in the skin. IgE may be important in the pathogenesis of clinical bluetongue (BT) disease in cattle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989843

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  5 in total

1.  Differential serologic responses to reassortant bluetongue viruses recovered from a bull.

Authors:  M S Maia; B I Osburn
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  A seroepidemiological study on bluetongue virus in dairy cattle in the central valley of California.

Authors:  I J Uhaa; H P Riemann; M C Thurmond; C E Franti
Journal:  Vet Res Commun       Date:  1990       Impact factor: 2.459

3.  Simultaneous detection of Rift Valley Fever, bluetongue, rinderpest, and Peste des petits ruminants viruses by a single-tube multiplex reverse transcriptase-PCR assay using a dual-priming oligonucleotide system.

Authors:  Jung-Yong Yeh; Ji-Hye Lee; Hyun-Ji Seo; Jee-Yong Park; Jin-San Moon; In-Soo Cho; In-Soo Choi; Seung-Yong Park; Chang-Seon Song; Joong-Bok Lee
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

4.  Multiple genome segments determine virulence of bluetongue virus serotype 8.

Authors:  Anna Janowicz; Marco Caporale; Andrew Shaw; Salvatore Gulletta; Luigina Di Gialleonardo; Maxime Ratinier; Massimo Palmarini
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

5.  Bluetongue Virus NS4 Protein Is an Interferon Antagonist and a Determinant of Virus Virulence.

Authors:  Maxime Ratinier; Andrew E Shaw; Gerald Barry; Quan Gu; Luigina Di Gialleonardo; Anna Janowicz; Mariana Varela; Richard E Randall; Marco Caporale; Massimo Palmarini
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.